The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict WellPoint's revenues will grow 1.0% and EPS will grow 4.0%.
The average estimate for revenue is $15.31 billion. On the bottom line, the average EPS estimate is $1.84.
Last quarter, WellPoint recorded revenue of $15.17 billion. GAAP reported sales were 2.0% higher than the prior-year quarter's $15.10 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $2.04. GAAP EPS of $1.94 for Q2 were 2.6% higher than the prior-year quarter's $1.89 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 21.5%, 40 basis points better than the prior-year quarter. Operating margin was 7.6%, 20 basis points better than the prior-year quarter. Net margin was 4.2%, 40 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $61.07 billion. The average EPS estimate is $7.34.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 942 members out of 1,000 rating the stock outperform, and 58 members rating it underperform. Among 310 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 303 give WellPoint a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WellPoint is outperform, with an average price target of $83.89.
- Add WellPoint to My Watchlist.